Consistent with this, our results showed that the administration of sPD-L1 reduced inflammatory lung injury in mice with direct ARDS, which may be attributed to the decrease of proinflammatory macrophages. This evidence concerns the gene SPDL1 and acute respiratory distress syndrome.